SHOX2 was significantly hypermethylated in BAL from early-stage NSCLC compared to controls (p < 0.01) (Figure 4D) with an AUROC of 0.71 ((95% CI, 0.56–0.86), p = 0.01) (Figure 4E). This evidence concerns the gene SHOX2 and non-small cell lung carcinoma.